Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 nm » 100 nm (Expand Search), 10 mm (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 nm » 100 nm (Expand Search), 10 mm (Expand Search)
-
1121
-
1122
-
1123
-
1124
-
1125
-
1126
-
1127
-
1128
-
1129
Zileuton, 5-Lipoxygenase Inhibitor, Acts as a Chemopreventive Agent in Intestinal Polyposis, by Modulating Polyp and Systemic Inflammation
Published 2015“…Here we report that Zileuton, a specific 5-LO inhibitor, can prevent polyp formation by efficiently reducing the tumor-associated and systemic inflammation in APC<sup>Δ468</sup> mice.…”
-
1130
-
1131
-
1132
-
1133
Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count.
Published 2025“…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”
-
1134
Tonic nM DA stabilizes the timing of LP activity over the short term.
Published 2015“…<b>(B) The timing of LP activity is stabilized by 5nM DA</b>. In order to visually compare the timing of LP activity at t = 0,1min and 20min, we performed the following manipulations on each the two sets of traces shown in panel A. …”
-
1135
-
1136
-
1137
-
1138
-
1139
-
1140
The MTT assay to determine decreases in residual cell viability in SK-N-BE2 and IMR-32 cells.
Published 2013“…(a) Treatments (24 h): treated CTL cells, CTL shRNA plasmid, LC3 shRNA plasmid, GST, LC3 shRNA plasmid + GST, 10 µM cisplatin, and 10 µM cyclophosphamide. …”